Trials / Unknown
UnknownNCT04687410
Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs
Randomized Comparison of Tissue Quality and Molecular Yield Between a Novel Crown-cut Biopsy Needle (FNB) and a Standard Aspiration Needle (FNA) for EUS Guided Diagnosis of Solid Pancreatic Lesions
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Peter Vilmann MD, DSc, HC, FASGE · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare tissue quality and molecular yield between a novel crown-cut biopsy needle (FNB) and a standard aspiration needle (FNA) for EUS-guided diagnosis of solid pancreatic lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ProControl, MediGlobe | standard 22G FNA needle |
| DEVICE | TopGain, Medi-Globe | novel 22G crown-cut FNB needle |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2021-04-01
- Completion
- 2021-06-01
- First posted
- 2020-12-29
- Last updated
- 2020-12-29
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04687410. Inclusion in this directory is not an endorsement.